Skip to content
Company Analysis

LeMaitre Vascular, Inc. LMAT

A comprehensive view of key metrics, scores, and financial health for LeMaitre Vascular, Inc.

Overview of LeMaitre Vascular, Inc.

LMAT NGM
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Mid Cap
LeMaitre Vascular, Inc. (LMAT), is a Mid Cap company, in the Medical Instruments & Supplies industry, last closed at $91.96, about 77.3% overvalued vs fair value, +12.0% 1Y return, placing in the top 10% of its sector.
Metrics Rev Growth 13.5% ROE 15.8% Gross Margin 71.5%
USD 91.96
-0.41%
(Delayed)
• Vol 90d: 47.6%
52-Week Range
Market Cap
$2.11B
Enterprise Value
$2.27B
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Excellent
Health
Fair
Efficiency
Fair
Valuation
Good
Growth
Good
Profitability
Excellent
Health
Fair
Efficiency
Fair
Valuation
Good
Completeness: 82%
Confidence: 89%
Updated: Mar 8
Top Beats

Quick Facts

Website https://www.lemaitre.com
HQ Burlington, MA
Employees 646
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$19
$21
$23
Current: $91.96 -77% vs base

Engine Room Money Flow™

Mid Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$249.6M
13.5%%
Gross Profit
$178.5M
18.3%%
Operating Income (GAAP)
$67.9M
30%%
EBITDA
$90.8M
36%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
71.5%
Excellent

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$16.1M
43.3% of Free Cash Flow

Where It Leaks

Cash Flow Health some concerns
Moderate efficiency issues detected. Review active leaks below for improvement areas.
3
Active Leaks
2/3
Improving
1
High Impact
0
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating LeMaitre Vascular, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
75
/100
Strong
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
75
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 100% Coverage
Trade-Off Triangle Visualization A ternary plot showing LMAT's balance between Growth (30.7%), Profitability (38.7%), and Safety (30.6%). Growth 31% Safety 31% Profitability 39%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

68th percentile vs peers
68
Key Signals
Rev Growth YoY 13.5% 64p Revenue CAGR 3Y 15.6% 66p EPS Growth YoY 44.0% 64p EPS CAGR 3Y 15.6% 65p TSR 86.0% 90p
Strengths
  • FCF Margin in top 20% of peers (16.9%, 90th percentile)
  • Gross Profit Margin in top 20% of peers (71.5%, 80th percentile)
  • Operating Margin in top 20% of peers (27.2%, 94th percentile)
  • ROIC in top 20% of peers (8.0%, 80th percentile)
Risks

No significant risks identified for this axis.

Profitability

86th percentile vs peers
86
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

68th percentile vs peers
68
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for LeMaitre Vascular, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$20.86
- - -
-77.3% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000